WHBF News

DHS supports CDC recommendation to expand eligibility for COVID-19 booster shots The Wisconsin Department of Health Services (DHS) supports the Centers for Disease Control and Prevention’s (CDC) recommendation that certain populations who have increased risk of exposure to or transmission of COVID-19 receive a booster shot...

An upcoming clinical study in Madison will explore if mRNA COVID-19 vaccines could cause allergic reactions in people who are considered “highly allergic.”  The UW School of Medicine and Public Health is recruiting participants aged 12 and older for the study. They are seeking those who’ve...

COVID-19 infections and related deaths continue to rise at nursing homes in Wisconsin, the latest numbers from AARP show.  Over the four weeks ending Sept. 19, the rate of COVID-19 deaths more than doubled from 0.05 to 0.11 per 100 residents, according to the organization’s nursing...

Anand Padmanabhan never thought he'd be an entrepreneur. But while working as a physician and scientist at the Versiti Blood Center of Wisconsin and the Medical College of Wisconsin (MCW), he discovered a new way to diagnose a sometimes life-threatening blood clotting complication called heparin-induced thrombocytopenia (HIT). Padmanabhan...

Researchers at UW-Madison have developed a multi-layered coating technique for probiotics that could improve how diseases are treated with these medications.  Probiotics consist of helpful bacteria that can be used to treat intestinal problems such as inflammatory bowel disease. They have been shown to improve the...

Two UW-Madison researchers will be conducting a clinical study on a psilocybin-based drug being developed by a Canadian pharmaceutical company. Psilocybin is the psychoactive component of so-called "magic mushrooms," which scientists around the world are studying as a potential method for treating mental health issues...